PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1383
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search